John Duncan Higgons

CIK 1581954 · Chief Operating Officer · last filed 2022-06-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.56M

Companies

2

Total Filings

46

Lifetime Open-Market Net

-$21.37M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Jounce Therapeutics, Inc. (JNCE) Delisted Director 9,713 $1.88 $18.3K $67.9K 12 2022-06-28
AGIO Chief Operating Officer 120,834 $29.46 $3.56M -$21.43M 34 2016-01-05

Recent Filings · Page 4 of 5

46 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-01-06 AGIO Sell (S) −12,000 -$1.32M EDGAR
2015-01-06 AGIO Sell (S) −12,000 -$1.32M EDGAR
2014-12-02 AGIO Sell (S) −12,000 -$1.16M EDGAR
2014-11-04 AGIO Sell (S) −13,000 -$1.06M EDGAR
2014-10-03 AGIO Sell (S) −13,000 -$780.9K EDGAR
2014-09-03 AGIO Mixed −6,255 -$599.9K EDGAR
2014-08-28 AGIO Mixed -$223.7K EDGAR
2014-08-05 AGIO Mixed -$271.5K EDGAR
2014-07-02 AGIO Sell (S) −12,000 -$558.2K EDGAR
2014-03-20 AGIO Exer (M) +80,000 $24.2K EDGAR
Showing 3140 of 46
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.